U.S. STOCKS Fulcrum Therapeutics, Summit Therapeutics, Signet Jewelers
Eikon search string for individual stock moves: STXBZ
The Day Ahead newsletter: https://refini.tv/3LI4BU7
The Morning News Call newsletter: https://refini.tv/3dKUyB8
Wall Street futures edged higher on Thursday ahead of upcoming economic data in the lead up to the Federal Reserve's likely interest rate cut next week. .N
At 9:08 ET, Dow e-minis 1YMc1 were up 0.10% at 40,945. S&P 500 e-minis ESc1 were up 0.12% at 5,568, while Nasdaq 100 e-minis NQc1 were up 0.01% at 19,273.5.
The top three NYSE percentage gainers premarket .PRPG.NQ:
** Montrose Environmental Group MEG, up 18.5%
** Signet Jewelers SIG, up 13.8%
** Medical Properties Trust MPW, up 13.1%
The top two NYSE percentage losers premarket .PRPL.NQ:
** Torrid Holdings CURV.K, down 17.5%
** Caleres CAL, down 16.8%
The top two Nasdaq percentage gainers premarket .PRPG.O:
** Tenon Medical TNON.O, up 141.8%
** Monopar Therapeutics MNPR.O, up 104.2%
The top two Nasdaq percentage losers premarket .PRPL.O:
** Fulcrum Therapeutics FULC.O, down 64.1%
** Syra Health Corp SYRA.O, down 53.8%
** U.S. Bancorp USB.N: up 1.6% premarket
BUZZ - Rises on $5 bln stock repurchase program nL4N3KU0R3
** Viper Energy Inc VNOM.O: down 4.6% premarket
BUZZ - Slips on pricing stock offering for acquisition nL1N3KU0C1
** Alaska Air Group Inc ALK.N: up 4.0% premarket
BUZZ - Up after Q3 outlook boost nL4N3KU0S6
** Moderna Inc MRNA.O: down 13.8% premarket
BUZZ - Slides on forecasting FY25 revenue below estimates nL4N3KU0RS
** Medical Properties Trust Inc MPW.N: up 13.1% premarket
BUZZ - Rises after settlement with Steward Health nL4N3KU0S0
** Torrid Holdings Inc CURV.N: down 17.5% premarket
BUZZ - Shares extend slump as secondary offering prices nL1N3KU0DU
** Aura Biosciences Inc AURA.O: up 9.2% premarket
BUZZ - Rises after data from mid-stage study of cancer treatment nL4N3KU0WF
** Lovesac Co LOVE.O: up 3.5% premarket
BUZZ - Rises on Q2 revenue beat nL4N3KU0X1
** Summit Therapeutics Inc SMMT.O: up 8.9% premarket
BUZZ - Rises on $235 mln capital-raise nL4N3KU0SR
** Signet Jewelers Ltd SIG.N: up 13.8% premarket
BUZZ - Jumps on better-than-expected Q3 sales forecast nL4N3KU0YR
** Fulcrum Therapeutic Inc FULC.O: down 64.1% premarket
BUZZ - Tanks as muscle disorder drug fails in late-stage study nL4N3KU0Z1
** Elf Beauty Inc ELF.N: up 1.2% premarket
BUZZ - TD Cowen cuts Elf Beauty's PT on slowing growth rate nL4N3KU10N
** Dow Inc DOW.N: down 0.8% premarket
BUZZ - Falls after lowering Q3 revenue expectations nL4N3KU10Z
(Compiled by Rajarshi Roy and Kashish Tandon)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
